Tumor‐bearing mice were intravenously injected with NE/CAMPs or NEs alone twice after average tumor volume reached 70–80 mm3, and an intraperitoneal treatment of aPD‐1 was started 3 days after the second NE/CAMP treatment (Figure 2a). This evidence concerns the gene CAMP and neoplasm.